Learn, Analyse & Invest
only with
only with
+91
Download Orca
Lactose (India) Ltd.
Lactose India
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹1.42 Cr.
| EX-Date | Purpose |
|---|---|
| 21 06 2021 | Audited Results |
| 12 08 2021 | Quarterly Results |
| 30 08 2021 | Inter alia, to consider the following business: 1. Director s Report along with annexure for the year ended 31* March, 2021; 2. Draft Notice Convening 30 Annual General Meeting of the company; 3. Any other business with the permission of chair. Kindly take the record of the same. |
| 12 11 2021 | Quarterly Results |
| 11 12 2021 | Inter alia, to consider and approve inter alia the following business: 1. To Approve and Allot Second Tranche of Equity Shares on conversion of convertible warrants into equity shares of face value of INR. 10/- each at the price of INR 21/- each (including premium of INR. 11/-) issued on preferential basis. 2. Any other business with the permission of chair. |
| 30 12 2021 | Inter alia, to consider and approve : 1. Resignation of Mr. Shyamsundar Toshniwal (Non-executive Director and chairman) and Mr. Mahendra Singhi (Independent Director). 2. Any other business. |
| 14 02 2022 | Quarterly Results |
| 19 03 2022 | Inter alia, to consider and approve appointment of Non-Executive Additional independent Director |
| 28 03 2022 | Preferential Issue of shares |
| 17 05 2022 | Audited Results & Inter alia, to consider and approve : 1. Audited Financial Results of the Company for the fourth quarter and Financial year ended 31st March, 2022. 2. Audited Financial Statements of the Company for the Financial year ended 31st March, 2022. 3. Director s Report along with annexure for the year ended 31st March, 2022; 4. Draft Notice Convening 31st Annual General Meeting of the company; 5. Any other business with the permission of chair. |
| 09 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 30 05 2023 | Audited Results |
| 27 07 2023 | Inter alia, to consider and approve:- 1. To approve the Director?s Report for the Financial Year Ended 31st March, 2023. 2. To approve of draft notice of Annual General Meeting of the Company and fix to fix the time, place, date of the meeting. 3. To approve re-appointment of Director who?s retiring by rotation. 4. Appointment of Cost Auditor. 5. To consider and approve the Internal Audit Report for the FY 2022-23. 6. To consider and approve the Secretarial Audit Report for the FY 2022-23. 7. To appoint M/s. Jajodia & Associates, Practising Company Secretary as a Scrutinizer for the upcoming AGM. 8. To approve Related Party Transactions for the FY 2023-24 to FY 2025-26. 9. To appoint Internal Auditors for the FY 2023-24. 10. To appoint Secretarial Auditors for the FY 2023-24. 11. To consider any other business with the permission of chair. |
| 14 08 2023 | Quarterly Results |
| 02 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 15 10 2024 | Quarterly Results & Inter alia, to consider and approve:- 1.To take on record resignation of Statutory Auditor M/s. S G C O & Co. LLP w.e.f. 09th October, 2024. 2.To consider any other business with the permission of chair |
| 21 10 2024 | Inter alia, to consider and approve:- 1. To appoint M/s. DMKH & Co, Chartered Accountants, as statutory auditors in casual vacancy; 2. To consider any other business with the permission of chair. |
| 23 10 2024 | Inter alia, to consider and approve:- 1. To consider issue upto 15,00,000 (Fifteen Lakhs) convertible warrants on preferential basis, in accordance with Section 42 and 62(1)(c) of the Companies Act, 2013 and all other applicable provisions, if any, (including any statutory modification(s) or re-enactments thereof for the time being in force), Memorandum and Articles of Association of the Company, SEBI (LODR), and in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and to fix the date, time and venue of the Extra Ordinary General Meeting of the members of the company for their approval of the funds proposed to be raised; 2. To approve the scheme of merger between Lactose (India) Limited and Vitanosh Ingredients Private Limited; 3. To consider any other business with the permission of chair. |
| 05 12 2024 | Inter alia, to consider and approve : 1. Allotment of 15,00,000 Convertible Warrants on preferential basis. 2. Any other business with the permission of chair. |
| 12 02 2025 | Quarterly Results |
| 30 05 2025 | Quarterly Results |
| 13 08 2025 | Quarterly Results |
| 13 11 2025 | Quarterly Results |
| 13 02 2026 | Quarterly Results |
News
No News data available
